The answer to improving survival rates in people with severe respiratory complications caused by COVID-19 is a generic steroid drug that can be bought for a few pounds.
UK firm hVIVO has launched a coronavirus antibody testing service for big businesses that it says could help get employees back to work as lockdown eases.
A scientist leading the development of Oxford University’s coronavirus vaccine says the just-started phase 2/3 trial only has a 50:50 chance of success, because the virus is di
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.